COVID-19 News, Member News

Thompson Hine | Government Measures Taken in Response to COVID-19: Country-by-Country Guide 2.0

Since April 2020, we have collaborated with our foreign law firm partners to provide a chart summarizing the economic, labor and employment, health and safety, and export and import measures taken by governments around the world in response to the COVID-19 pandemic. After a short break, we are back with version 2.0 of our chart with substantive changes to reflect the most pressing and interesting government measures concerning the COVID-19 pandemic. The new version of the chart includes a concise, corporate-focused...

Read more

COVID-19 News, Member News

EIB | BioNTech moves to head of pack in fight against coronavirus

EU financing for COVID-19 vaccine helps German firm close in on a solution with highly effective trial results When Özlem Türeci and her husband, Uğur Şahin, announced that the COVID-19 vaccine developed by their company, BioNTech, had excellent results in its latest tests, the couple took a short break from their round-the-clock research schedule. But only long enough to drink a cup of tea. “It was oolong tea to be precise,” Türeci says. “We both like it and it’s easy to...

Read more

Chapter News, COVID-19 News

Coronavirus: EU Commission approves contract with CureVac to ensure access to a potential vaccine

Today, the European Commission approved a fifth contract with the European pharmaceutical company CureVac, which provides for the initial purchase of 225 million doses on behalf of all EU Member States, plus an option to request up to a further 180 million doses, to be supplied once a vaccine has proven to be safe and effective against COVID-19. Today's contract with CureVac enlarges the already broad portfolio of vaccines to be produced in Europe, including the contracts signed with AstraZeneca, Sanofi-GSK, Janssen Pharmaceutica...

Read more

Chapter News, COVID-19 News

EU Commission disburses €14 billion under SURE to nine Member States

The European Commission has disbursed €14 billion to nine EU countries in the second installment of financial support to Member States under the SURE instrument. As part of today's operations, Croatia has received €510 million, Cyprus €250 million, Greece €2 billion, Italy an additional €6.5 billion, Latvia €120 million, Lithuania €300 million, Malta €120 million, Slovenia €200 million and Spain an additional €4 billion. This support, in the form of loans granted on favourable terms, will assist these Member States...

Read more

COVID-19 News, Member News

H&K | COVID-19 Vaccinations Are Coming, But What Will the PREP Act Immunize?

Highlights: Due to the recent announcements of successful trials for a COVID-19 vaccine, healthcare providers are asking about the extent to which the Public Readiness and Emergency Preparedness Act (PREP Act) will protect them against liability under state and federal law. There is limited case law addressing the applicability of the PREP Act, but the bottom line of the few cases that have examined the question is that the PREP Act is likely to preempt state claims relating to...

Read more

COVID-19 News, Member News

Vulcan Insight | EU Health Union: A Commission rethink on health crisis response

In the wake of the COVID-19 pandemic, the European Commission proposed on Wednesday to create a European Health Union to better equip the EU for the prevention, preparation and management of health crises. In its communication, the Commission said that in order to save lives and livelihoods it would push for a more resilient EU internal market and a sustained economic recovery. The draft proposal, which follows on from the State of the Union address by the President of the...

Read more

Chapter News, COVID-19 News

New Consumer Agenda: European Commission to empower consumers to become the driver of transition

Today, the European Commission launched the New Consumer Agenda to empower European consumers to play an active role in the green and digital transitions. The Agenda also addresses how to increase consumer protection and resilience during and after the COVID-19 pandemic, which brought significant challenges affecting the daily lives of consumers. More concretely, the Agenda puts forward priorities and key action points to be taken in the next 5 years together with Member States at European and national levels. This will,...

Read more

COVID-19 News, Member News

Portolano | Foreign investment control in the life science sector: the scope of the Italian Government’s powers also in the context of the current COVID-19 pandemic

This article is part of Portolano’s bimonthly “INFORM@ Life Sciences” Newsletter. Click here to subscribe. | Some recent cases in the news, as well as steps taken to increase the regulatory powers of the government in the current emergency situation via the Decreto Liquidità, have prompted us to draft this overview of measures that provide the government with special powers that it may exercise to prohibit or impose conditions upon extraordinary corporate transactions of foreign parties involving Italian target companies...

Read more

Chapter News, COVID-19 News

Coronavirus: EU Commission approves contract with BioNTech-Pfizer alliance to ensure access to a potential vaccine

Today, the European Commission approved a fourth contract with pharmaceutical companies BioNTech and Pfizer, which provides for the initial purchase of 200 million doses on behalf of all EU Member States, plus an option to request up to a further 100 million doses, to be supplied once a vaccine has proven to be safe and effective against COVID-19. Member States can decide to donate the vaccine to lower and middle-income countries or to re-direct it to other European countries. Today's...

Read more

Chapter News, COVID-19 News

President von der Leyen on the authorisation of the contract for vaccines with Pfizer and BioNTech

Statement by President von der Leyen on 10 November, 2020 | "A safe and effective vaccine is our best chance to beat coronavirus and return to our normal lives. In the past months, the European Commission has been working tirelessly to secure doses of potential vaccines. And tomorrow we authorise a contract for up to 300 million doses of the vaccine developed by German company BioNTech and Pfizer. This is the most promising vaccine so far. Once this vaccine becomes available, our plan...

Read more